Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complications

[1] Partin AW(1997)Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 277 1445-1451

[2] Kattan MW(2006)Evidence to support a continued stage migration and decrease in prostate cancer specific mortality J Urol 175 907-912

[3] Subong EN(2010)Time trends and local variation in primary treatment of localized prostate cancer J Clin Oncol 28 1117-1123

[4] Galper SL(2008)Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes Cancer 112 307-314

[5] Chen MH(2002)Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor J Urol 168 530-535

[6] Catalona WJ(2010)Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden Lancet Oncol 11 450-458

[7] Cooperberg MR(2010)Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer J Nat Cancer Inst 102 39-46

[8] Broering JM(1999)Salvage brachytherapy for localized prostate cancer after radiotherapy failure Urology 53 2-10

[9] Carroll PR(2003)Serial histopathology results of salvage cryoablation for prostate cancer after radiation failure J Urol 170 1199-1202

[10] Agarwal PK(2010)Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy BJU Int 105 191-201

[1] Partin AW(1997)Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 277 1445-1451

[2] Kattan MW(2006)Evidence to support a continued stage migration and decrease in prostate cancer specific mortality J Urol 175 907-912

[3] Subong EN(2010)Time trends and local variation in primary treatment of localized prostate cancer J Clin Oncol 28 1117-1123

[4] Galper SL(2008)Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes Cancer 112 307-314

[5] Chen MH(2002)Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor J Urol 168 530-535

[6] Catalona WJ(2010)Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden Lancet Oncol 11 450-458

[7] Cooperberg MR(2010)Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer J Nat Cancer Inst 102 39-46

[8] Broering JM(1999)Salvage brachytherapy for localized prostate cancer after radiotherapy failure Urology 53 2-10

[9] Carroll PR(2003)Serial histopathology results of salvage cryoablation for prostate cancer after radiation failure J Urol 170 1199-1202

[10] Agarwal PK(2010)Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy BJU Int 105 191-201